Ngā hua rapu kaituhi

1

AMPA Receptor Calcium Permeability, GluR2 Expression, and Selective Motoneuron Vulnerability mā Wim Vandenberghe, Wim Robberecht, James R. Brorson

I whakaputaina 2000

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke mā Robin Lemmens, Tom Jaspers, Wim Robberecht, Vincent Thijs

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis mā Annelies Nonneman, Wim Robberecht, Ludo Van Den Bosch

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

RNA toxicity in non‐coding repeat expansion disorders mā Bart Swinnen, Wim Robberecht, Ludo Van Den Bosch

I whakaputaina 2019

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Modelling amyotrophic lateral sclerosis: progress and possibilities mā Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS) mā Lindsay Poppe, Laura Rué, Wim Robberecht, Ludo Van Den Bosch

I whakaputaina 2014

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis mā Philip Van Damme, Dries Braeken, Geert Callewaert, Wim Robberecht, Ludo Van Den Bosch

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

GluR2-Dependent Properties of AMPA Receptors Determine the Selective Vulnerability of Motor Neurons to Excitotoxicity mā Philip Van Damme, Ludo Van Den Bosch, E Van Houtte, Geert Callewaert, Wim Robberecht

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging mā Vincent Thijs, Diederik M. Somford, Roland Bammer, Wim Robberecht, Michael E. Moseley, Gregory W. Albers

I whakaputaina 2003

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Prospective Validation of <sup>18</sup>F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis mā Donatienne Van Weehaeghe, Jenny Ceccarini, Aline Delva, Wim Robberecht, Philip Van Damme, Koen Van Laere

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Upregulation of HSP27 in a Transgenic Model of ALS mā V. Vleminckx, Philip Van Damme, Karolien Goffin, Hans Delye, Ludo Van Den Bosch, Wim Robberecht

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Noninvasive Ventilation Improves Sleep in Amyotrophic Lateral Sclerosis: A Prospective Polysomnographic Study mā Bart Vrijsen, Bertien Buyse, Catharina Belge, Wim Robberecht, Philip Van Damme, Marc Decramer, Dries Testelmans

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T)mice mā Sarah Herdewyn, Carla Cirillo, Ludo Van Den Bosch, Wim Robberecht, Pieter Vanden Berghe, Philip Van Damme

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease mā Veronick Benoy, Pieter Vanden Berghe, Matthew Jarpe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Value of<sup>18</sup>Fluorodeoxyglucose–Positron-Emission Tomography in Amyotrophic Lateral Sclerosis mā Koen Van Laere, Annelies Vanhee, Jolien Verschueren, Liesbeth De Coster, An Driesen, Patrick Dupont, Wim Robberecht, Philip Van Damme

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy mā Angela S. Laird, Annelies Van Hoecke, Louis De Muynck, Mieke Timmers, Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins mā Jolien Steyaert, Wendy Scheveneels, J. Vanneste, Philip Van Damme, Wim Robberecht, Patrick Callaerts, Elke Bogaert, Ludo Van Den Bosch

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study mā Greet Hermans, Maarten Schrooten, Philip Van Damme, N. Berends, Bernard Bouckaert, Wouter De Vooght, Wim Robberecht, Greet Van den Berghe

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS mā Ines Taes, Mieke Timmers, Nicole Hersmus, André Bento‐Abreu, Ludo Van Den Bosch, Philip Van Damme, Johan Auwerx, Wim Robberecht

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: Revisited mā Caroline Sage, Wim Van Hecke, Ronald Peeters, Jan Sijbers, Wim Robberecht, Paul M. Parizel, Guy Marchal, Alexander Leemans, Stefan Sunaert

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Wim Robberecht

AMPA Receptor Calcium Permeability, GluR2 Expression, and Selective Motoneuron Vulnerability mā Wim Vandenberghe, Wim Robberecht, James R. Brorson

Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke mā Robin Lemmens, Tom Jaspers, Wim Robberecht, Vincent Thijs

The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis mā Annelies Nonneman, Wim Robberecht, Ludo Van Den Bosch

RNA toxicity in non‐coding repeat expansion disorders mā Bart Swinnen, Wim Robberecht, Ludo Van Den Bosch

Modelling amyotrophic lateral sclerosis: progress and possibilities mā Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch

Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS) mā Lindsay Poppe, Laura Rué, Wim Robberecht, Ludo Van Den Bosch

GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis mā Philip Van Damme, Dries Braeken, Geert Callewaert, Wim Robberecht, Ludo Van Den Bosch

GluR2-Dependent Properties of AMPA Receptors Determine the Selective Vulnerability of Motor Neurons to Excitotoxicity mā Philip Van Damme, Ludo Van Den Bosch, E Van Houtte, Geert Callewaert, Wim Robberecht

Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging mā Vincent Thijs, Diederik M. Somford, Roland Bammer, Wim Robberecht, Michael E. Moseley, Gregory W. Albers

Prospective Validation of <sup>18</sup>F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis mā Donatienne Van Weehaeghe, Jenny Ceccarini, Aline Delva, Wim Robberecht, Philip Van Damme, Koen Van Laere

Upregulation of HSP27 in a Transgenic Model of ALS mā V. Vleminckx, Philip Van Damme, Karolien Goffin, Hans Delye, Ludo Van Den Bosch, Wim Robberecht

Noninvasive Ventilation Improves Sleep in Amyotrophic Lateral Sclerosis: A Prospective Polysomnographic Study mā Bart Vrijsen, Bertien Buyse, Catharina Belge, Wim Robberecht, Philip Van Damme, Marc Decramer, Dries Testelmans

Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T)mice mā Sarah Herdewyn, Carla Cirillo, Ludo Van Den Bosch, Wim Robberecht, Pieter Vanden Berghe, Philip Van Damme

Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease mā Veronick Benoy, Pieter Vanden Berghe, Matthew Jarpe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch

Value of<sup>18</sup>Fluorodeoxyglucose–Positron-Emission Tomography in Amyotrophic Lateral Sclerosis mā Koen Van Laere, Annelies Vanhee, Jolien Verschueren, Liesbeth De Coster, An Driesen, Patrick Dupont, Wim Robberecht, Philip Van Damme

Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy mā Angela S. Laird, Annelies Van Hoecke, Louis De Muynck, Mieke Timmers, Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht

FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins mā Jolien Steyaert, Wendy Scheveneels, J. Vanneste, Philip Van Damme, Wim Robberecht, Patrick Callaerts, Elke Bogaert, Ludo Van Den Bosch

Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study mā Greet Hermans, Maarten Schrooten, Philip Van Damme, N. Berends, Bernard Bouckaert, Wouter De Vooght, Wim Robberecht, Greet Van den Berghe

Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS mā Ines Taes, Mieke Timmers, Nicole Hersmus, André Bento‐Abreu, Ludo Van Den Bosch, Philip Van Damme, Johan Auwerx, Wim Robberecht

Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: Revisited mā Caroline Sage, Wim Van Hecke, Ronald Peeters, Jan Sijbers, Wim Robberecht, Paul M. Parizel, Guy Marchal, Alexander Leemans, Stefan Sunaert

Ngā utauta rapu:

Ngā marau whai pānga